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Introduction
Gas gangrene is also known as clostridial myonecro-
sis (lat. gangrenea gaseosa), a bacterial infection caused 
by anaerobic Gram-positive bacilli of the genus Clostri­
dium of a severe clinical course (Sołtys-Bolibrzuch, 
2012). Clostridium perfringens species is the most com-
monly isolated etiological factor for gas gangrene (up to 
90% of cases) (Knap, 2004; Stasiak et al., 2007).
The most common symptoms of gas gangrene are 
sudden, very severe pain, which responds poorly to 
painkillers, edema and erythema of the skin and soft 
tissues, epidermoid cysts filled with blood and serum 
or sanies, or similar fluid discharges from the wound, 
crepitus to the touch and a characteristic fetid smell. 
Furthermore, toxemia-related general symptoms pre-
sent themselves; also, there are manifestations of the 
toxic shock syndrome and the multiple organ dys-
function syndrome (MODS) (Sussmann et al., 1998; 
Martirosian, 2007).
A range of extracellular toxins determines C. per­
fringens pathogenesis. They were assigned consecutive 
letters of the Greek alphabet. Alpha-toxin (α), which 
is a major toxin, as well as theta-toxin (θ) and kappa-
toxin (κ) cause the local and systemic symptoms char-
acteristic of gas gangrene (Stevens and Bryant, 2002).
Among healthy individuals, primarily in elderly 
patients, the percentage of C. perfringens carriage ranges 
from 6% to 31% (Sobel et al., 2005). The frequency of 
gas gangrene occurrence, according to the literature in 
English, is estimated to be from 0.1 to 1.0 incidences per 
one million residents a year and is primarily associated 
with traumas (Sussmann et al., 1998). In the end of the 
20th century, in Great Britain, there were 70–80 cases 
reported a year; compared with 200–400 in the USA, 
while Polish estimates mention around 100 cases of gas 
gangrene a year (Knap, 2004).
Due to its high toxicity, which results in invasive-
ness, the species C. perfringens can be considered alert 
microorganisms in accordance with the regulation of 
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A b s t r a c t
The objective of the study was to perform a comparative analysis of phenotypic and genetic similarity, determination of resistance profiles, 
detection of toxin-encoding genes and molecular typing of Clostridium perfringens isolates originating from patients with gas gangrene. 
The study encompassed three patients with a clinical and microbiological diagnosis of gas gangrene who were hospitalized in one of the 
hospitals of the Kujawsko-Pomorskie province in the same period of time between 8th April 2015 and 20th April 2015. The three C. perfrin­
gens isolates studied had identical biochemical profiles. Two isolates had identical resistance patterns, while the third presented a different 
profile. Using the multiplex PCR method, all isolates showed the presence of cpa gene encoding α-toxin; furthermore, the presence of the 
cpb2 gene encoding β2-toxin was confirmed in two isolates. Genotyping with the use of pulsed field gel electrophoresis (PFGE) indicated 
that the isolates originating from the three studied patients represent three genetically different restrictive patterns which corresponded 
to three different clones – clone A, clone B and clone C. As a result of the study, it is possible to conclude that the studied patients simulta-
neously hospitalized in a single Department of Orthopedics and Traumatology developed three different endogenous infections.
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the Minister of Health in Poland of 23rd December 2011 
concerning the list of alert factors, hospital infections 
and alert factors records as well as reports on the cur-
rent epidemiological situation of the hospital (Ministe-
rial Decree, 2011).
Microbiological diagnostic analysis, together with 
clinical picture, form the basis for diagnosing gas gan-
grene. The former requires proper sampling of the 
material for testing, which is either a tissue fragment 
or sanies from the border of healthy tissues, and when it 
is impossible to obtain biopsy material, a swab is taken. 
Biological material makes it possible to prepare a direct 
smear which should be stained using the Gram stain 
technique and tested under the microscope for Gram-
positive cylindrical forms. It is common for direct 
smears not to contain leucocytes. It results from lytic 
activity of lecithinase and theta-toxin. Simultaneously, 
a culture for aerobic and anaerobic bacteria should be 
prepared using the biological material, which enables 
a conclusive confirmation of C. perfringens occurrence. 
Tissue biopsy material taken from the site affected by 
gas gangrene is subjected to a histopathological test to 
enable, in a way similar to direct smear, quick prelimi-
nary confirmation of the diagnosis. In order to diagnose 
gas gangrene and implement treatment, it is enough to 
have a clinical picture of the patient and detect the pres-
ence of Gram-positive cylindrical forms in the direct 
smear, while the C. perfringens culture serves to confirm 
the diagnosis (Sussmann et al., 1998; Martirosian, 2007).
Molecular methods employed for bacterial isolates 
typing make it possible to determine the genetic simi-
larity of species originating either from infections or 
from hospital environment (van Belkum et al., 2007).
For C. perfringens the toxin typing is very important 
because of particular toxin types are associated with 
the specific clinical course of the disease (Stevens and 
Bryant, 2002). A multiplex PCR method simultaneously 
detecting the four major toxin genes (cpa, cpb, etx, iap), 
the enterotoxin gene (cpe), and all variants of the beta2 
toxin gene (cpb2) (van Asten et al., 2009). 
Pulsed field gel electrophoresis (PFGE), which is 
recognized as the gold standard in microbial typing, 
make it possible to compare the genetic similarity of 
C. perfringens isolates, which permits genetically-iden-
tical bacterial clones to be selected (van Belkum et al., 
2007). It is a very helpful tool applied in epidemiological 
investigation of gas gangrene cases reported in patients 
hospitalized in the same hospital unit (Maslanka et al., 
1999; Brzychczy-Włoch et al., 2014). 
Objective of the study. The objective of the study 
was to perform a comparative analysis of phenotypic 
and genetic similarity of C. perfringens isolates origi-
nating from three patients with gas gangrene simulta-
neously hospitalized in a single Department of Ortho-
pedics and Traumatology in 2015.
Experimental
Materials and Methods
The study encompassed three patients with a clini-
cal and microbiological diagnosis of gas gangrene 
who were hospitalized in one of the hospitals of the 
Kujawsko-Pomorskie province in the time period 
between 15th April 2015 and 20th April 2015.
Description of the cases
Patient 1. A man aged 53 was admitted to the 
Department of Orthopedics and Traumatology on 
23  March 2015 as emergency inpatient with a  frac-
tured left tibial epiphysis due to a fall from a  ladder 
on the day of the admission. On 24 March a  plaster 
splint was applied and traction was used. Due to lower 
leg swelling, a surgical procedure was postponed. From 
23  March to 3  May, the patient received amoxicillin 
with clavulanic acid 3 × 1.2 g IV. On 2 April, the sur-
gical procedure was performed. Perioperative prophy-
laxis was provided with cefazolin 2g IV. After 8 days on 
10 April, the patient developed a fever. A knee puncture 
was performed. Bloody fluid was taken from the knee 
and sent for testing. Enterococcus faecalis was cultured 
aero bically and C. perfringens was cultured anaero-
bically from the material. The targeted therapy was 
used. Clindamycin was administered 3 × 600 mg  IV. 
On 15 April, wound debridement was carried out and 
intraoperative material was taken. C. perfringens was 
cultured anaerobically from the material (lab no. 7013); 
aerobically, there was no growth. On 23 April, clinda-
mycin was discontinued and metronidazole was started 
at a dose of 0.5 g IV × 8 h until 3 May. Wound irrigation 
was performed using hydrogen peroxide. Patient isola-
tion was implemented. The material from the patient 
was collected several times more until 2 May – cultures 
were negative. Consultation with Hyperbaric Oxygen 
Center in Gdansk was done. The patient was qualified 
for treatment as the wound was healing slowly, but 
the treatment was not applied. April, 24: wound 
debridement, removal of necrotic sections. Aqua-
cel Ag (ConvaTec Poland) foam dressing. April, 28: 
VivanoMed (Hartmann) vacuum dressing was applied 
for about 3 weeks. On 2 June, after 102 days of hospi-
talization the patient was discharged from hospital in 
a good condition.
Patient 2. A woman aged 88 was admitted to 
the Department of Orthopedics and Traumatology 
on 26  March 2015 after a fall at home. The diagno-
sis: a closed comminuted fracture of the right femur. 
Comorbidities: type 2 diabetes, atherosclerotic cardio-
myopathy, circulatory failure NYHA III, hyperten-
sion, cholecystolithiasis, erosive gastritis. On the day 
of admission, 3 units of packed red blood cells (PRBCs) 
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were transfused. On 27  March, a  surgical procedure 
was carried out involving fracture fixation with a stain-
less-steel popliteal intramedullary nail (Megdal). Perio-
perative prophylaxis was used – cefazolin 2 g IV. The 
patient was agitated on 28 April during the night, peri-
odically without contact. April, 30: patient’s condition 
is stable. On 2  April, moderately severe condition. 
Due to destabilization, reoperation to remove the fixa-
tion and an NCB (Zimmer) titanium femur plate was 
placed. After 24 h, the swelling without symptoms of 
crepitus of the affected limb. Two units of PRBCs were 
transfused and material from the wound was collected. 
On 7 April, ciprofloxacin was administered 2 × 750 mg 
IV until 13 April. On 9 April, material was taken for 
testing. There was lack of growth of aerobic flora (there 
was no culture for anaerobic bacteria). Lack of pro-
gress in wound healing. Discharge of a small amount 
of serum. Octenisept (Schulke S&M) rinsing was 
employed and Cosmopor (Hartmann) dressings. On 
17 April, material for testing was collected. C. perfrin­
gens (lab no. 7149) was cultured; aerobically, no growth. 
From 17 April, amoxicillin with clavulanic acid was 
started 3 × 2.4 g  IV in combination with clindamycin 
3 × 600 mg IV until 20 April. On the night of 19 April, 
deterioration of patient’s condition. Symptoms of cir-
culatory failure. The patient received oxygen therapy. 
April, 20, on the 26th hospital day: Patient’s death due 
to multiorgan failure.
Patient 3. A woman aged 76 was admitted to the 
Department of Orthopedics and Traumatology on 
8 April 2015 as emergency inpatient. As a result of a fall 
at home, she suffered a right thigh injury. Diagnosis: 
comminuted closed fracture of the femur. Comor-
bidities: hypertension, ischemic heart disease, type 2 
diabetes. On 9  April, supramalleolar traction was 
employed. On 14  April, MIPO (minimally invasive 
plate osteosynthesis) thigh fixation surgery was car-
ried out with the use of the NCB (Zimmer) titanium 
plate. April, 17: deterioration of the patient’s condi-
tion, temperature increase to 38.9°C, pain in the limb, 
skin bruising. During the exam, a subcutaneous space 
was found, which showed symptoms of crepitus upon 
palpitation. The necrotic skin was incised with evi- 
dence of gas release and discharge of a significant 
amount of turbid dark liquid. Material for micro- 
bio logical testing was collected. C. perfringens (lab 
no. 7143) was cultured; aerobically – no growth. The 
resulting fistula was rinsed with hydrogen peroxide. 
From 17 April, amoxicillin with clavulanic acid was 
prescribed 3 × 1.2 g in combination with clindamycin 
3 × 600 mg IV. In view of the fulminant gas gangrene, 
on 17 April, a decision was made to amputate the limb, 
however, the patient did not consent to surgery. On 
18 April, after obtaining the patient’s consent to ampu-
tate the limb, the life-saving procedure was undertaken. 
During the surgery, CPR was performed several times 
on the patient. Death occurred on the 10th hospital 
day during surgery. Final diagnosis: death due to infec-
tion with C. perfringens. 
Microbiological diagnostics. Materials for micro-
biological examination from the three studied patients 
were taken using sterile swabs for the Amies (COPAN) 
activated carbon substrate. Culturing was carried out 
on the Columbia Sheep Blood Agar (BioMérieux) 
medium under aerobic and anaerobic conditions as 
well as on liquid thioglycollate medium with resazurin 
(BioMaxima). Solid media with the inoculated material 
were incubated under aerobic conditions at 36°C/48 h 
and under anaerobic conditions at 36°C/24 h and the 
liquid medium under aerobic conditions (with a closed 
cap) at 36°C/48 h. Identification of the cultured bacte-
ria was carried out using the Vitek 2 compact system 
(BioMérieux). The biochemical patterns for C. per­
fringens isolates were received with the use of API 20A 
test (BioMérieux). 
The following strains of C. perfringens were pro-
tected for the further studies: from patient 1 – iso-
late no 7013; from patient 2 – isolate no  7149; from 
patient 3 – isolate no 7143. C. perfringens 12915 ATCC 
(The American Type Culture Collection) standard was 
used as reference strain. The strains were stored with 
the use of Cryobank (BioMaxima) at –70°C.
Protection of epidemic outbreak and epidemio-
logical investigation. On 15 April 2015, the ward and 
the epidemiological nurse were informed by phone by 
the Department of Microbiology Diagnostics about the 
isolation of an alert pathogen. The nurse went to the 
unit to arrange a method for patient isolation. Since 
the patient was in the Main Operating Theater, the 
Octenisept (Schulke S&M) sporicidal agent was used 
(for debridement and rinsing of the wound).
On 17 April, a meeting was held of the Hospital 
Infection Control Team and the Head of the Depart-
ment of Orthopedics and Traumatology on account 
of culturing an alert pathogen in patient no. 1 (lab 
no. 7013) and a suspicion in patient no. 3 (lab no. 7143). 
Intensification of the sanitary regime was established, 
together with isolation of patient no. 3, application of 
the Incidin Active (Ecolab) sporicidal agent for surface 
decontamination. Aniosept activ (Medilab) was used 
for surfaces and tools in the Main Operating Theater. 
Equipment was allocated to the isolated patients. An 
inspection was carried out of the compliance with han-
dling medical waste and bed linen (labeling of notifica-
tions according to the procedure in double red bags). 
The Head of the Main Operating Theater was instructed 
to execute preventative decontamination of all operat-
ing rooms with a sporicidal agent and to support it by 
fogging the rooms with HyPro technical 6–7% H2O2 
using the Hyspray (Hymetec) appliance.
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On 18 April, after oral information from the Depart-
ment of Microbiological Diagnostics concerning the 
suspicion of C. perfringens culture in patient no. 2 (lab 
no. 7149), patient isolation was continued, sanitary 
regime was intensified, and separate staff was assigned 
to the isolated patients. 
On 19 April, all the patients of the Ward were 
included into the outbreak – a total of 20 people. Action 
taken: contact isolation of patients; intensification of 
sanitary regime; dedication of separate equipment to 
isolated patients; assignment of staff to care for isolated 
patients; environmental control after each decontami-
nation procedure.
On 20 April, the Director of the Hospital decided 
not to perform the scheduled surgical procedures and 
to execute another general disinfection of the opera- 
ting rooms and equipment in conjunction with fog-
ging and taking environmental tests, including from the 
hands of workers in the operating theater, employees 
and surgical wards.
On 21 April until 29 April, in accordance with the 
decision of the District Sanitary Inspector, planned 
admissions to the surgical wards and scheduled surgical 
procedures were suspended. At that time, decontamina-
tion of rooms was carried out together with fogging and 
all surgical instruments were subjected to reprocessing.
Between 19 and 24 April, daily meetings were held 
involving the Infection Control Committee and the 
Hospital Administration with the purpose of discuss-
ing the current situation. 
Inspection of the decontamination of surfaces and 
hygienic hand washing was carried out by the contact 
plate method using Count-Tact (BioMérieux) system 
with the use of Agar Count-Tact (BioMérieux) radia-
tion-sterilized plates. Incubation of the plates under 
aerobic conditions at 30°C/72 h.
After the exhaustion of the stock of plates, further 
examination was carried out using swabs. Materials were 
collected on a sterile swab (COPAN) and subsequently 
placed in Tryptic Soy Broth (BioMaxima). Incubation 
was carried out at 36°C/72 h. Positive liquid cultures 
were plated on solid media: Columbia Agar, MacConkey 
Agar and Sabouraud Agar (BioMérieux). Each material 
was tested for aerobic and anaerobic flora.
Antibiotic susceptibility testing. To determine the 
drug-resistance profiles, the Kirby-Bauer disk diffu-
sion method was used in which the Columbia Sheep 
Blood Agar (BioMérieux) and antibiotic disks (Oxoid) 
were utilized: penicillin – P [1 U], imipenem – IPM 
[10 µg], amikacin – AK [30 µg], gentamicin – CN 
[10 µg], tobramycin – TOB [10 µg], netilmicin – NET 
[10 µg], metronidazole – MTZ [5 µg], chloramphenicol 
– C [30 µg] and the E-test method enabling determi-
nation of MIC (Minimal Inhibitory Concentration) 
for: ampicillin – AM, clindamycin – DA, doripenem 
– DOR, doxycycline – DC, ciprofloxacin – CI, vanco-
mycin – VA (bioMerieux). The results were interpreted 
according to The European Committee on Anti-
microbial Susceptibility Testing (EUCAST) version 5.0 
(EUCAST, 2015). 
PCR multiplex. To isolate DNA, the Genomic 
Mini Set (A&A Biotechnology) was used according 
to the manufacturer’s protocol. The presence of genes 
encoding toxins of C. perfringens was confirmed using 
multiplex PCR amplification according to van Asten 
et al. (van Asten et al., 2009) with specific primers 
(Genomed). The following genes were detected: cpa 
324 bp (α-toxin); cpb 195 bp (β-toxin); cpb2 548 bp 
(β2-toxin); etx 376 bp (ε-toxin); iap 272 bp (ζ-toxin); 
cpe 485 bp (enterotoxin). The final pictures from elec-
trophoresis were processed using QuantityOne soft-
ware, as well as GelDoc2000 device (Bio-Rad, USA).
Molecular typing with PFGE. The chosen C. per­
fringens isolates underwent molecular typing using the 
PFGE method according to the methodology described 
by Maslanka et al. (1999). Chromosomal DNA of bac-
terial strains was isolated in agarose blocks and then 
digested with the use of restriction enzyme Smal (MBI 
Fermentas). Electrophoretic separation was performed 
on CHEF-DR II (Bio-Rad) machine, while restriction 
analysis was carried out using GelCompar II (Applied 
Maths) software with the application of UPGMA clus-
tering method and Jaccard index. The obtained genetic 
profiles were interpreted according to the guidelines 
given by van Belkum et al. (2007).
Results
The diagnosis of gas gangrene made on the basis 
of clinical picture in the three patients hospitalized in 
the Department of Orthopedics and Traumatology of 
the district hospital was confirmed with microbio-
logical testing, in which C. perfringens strains were 
isolated from the intraoperative clinical materials: 
patient 1– isolate no. 7013; patient 2 – isolate no. 7149; 
patient 3 – isolate no. 7143. 
The first strain of C. perfringens no. 7013 was iso-
lated on 10 April 2015 (patient 1), and reported to 
the ward and the epidemiological nurse on 15 April. 
The second and third strains were isolated on 17 April 
(patient 2 and 3). On 6 May 2015, activities associated 
with eradicating the outbreak were completed.
During the epidemiological investigation, mate-
rials were taken in the amount of 173 from patients of 
the Department of Orthopedics and 140 from the staff 
of the Department of Orthopedics, General Surgery, 
Anaesthesia and Intensive Care, and the Main Oper-
ating Theater. 250 materials were also taken from the 
hospital environment (mainly the ward and operating 
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theater). None of the materials enabled culturing the 
C. perfringens alert pathogen.
With the use of API 20A (BioMérieux) test, bio-
chemical profiles of the isolates tested were estab-
lished (Table I) and they were identical for the isolates 
no. 7149 and no. 7143 (the second and the third patient) 
and different for isolate no. 7013 (the first patient). 
drug resistance profile. Using the E-test method the 
susceptibility to ampicillin, clindamycin, doripenem, 
doxycycline, ciprofloxacin and vancomycin were 
detected for the study isolates. Only isolate no. 7143 
from the third patient was resistant to clindamycin.
When multiplex PCR was applied, all C. perfrin­
gens isolates originating from the three patients dem-
onstrated the presence of cpa gene encoding α-toxin. 
Moreover, in isolate no. 7149 coming from patient 2 and 
in isolate no. 7143 from patient 3, cpb2 gene encoding 
β2-toxin presence was confirmed (Fig. 1; Table III).
Patient 1 7013 – – + – + + + – – – + – – – + – – – – + – + + –
Patient 2 7149  – – + – + + + – – – + – + – + – – – – + – + + –
Patient 3 7143 – – + – + + + – – – + – + – + – – – – + – + + –
Table I




























































Penicillin 35 35 35
Imipenem 35 35 35
Amikacin 32 24 5
Gentamicin 30 22 5
Tobramycin 30 22 5
Netilmicin 30 22 5
Metronidazole 5 5 5
Chloramphenicol 35 35 35
Table II













Ampicillin 0.016 0.016 0.016
Clindamycin 0.064 0.19 48
Doripenem 0.064 0.064 0.064
Doxycycline 0.19 0.125 2
Chloramphenicol 0.25 0.19 0.25
Vancomycin 0.016 0.016 0.016
The E-test method Minimal inhibitory concentration;MIC [mg/l]
Fig. 1. Detection of genes encoding virulence factors
of C. perfringens by multiplex PCR method.
M – size marker; 1 – negative control (H2O); 2 – reference strain
of C. perfringens ATCC 12915; 3 – C. perfringens isolate no. 7143 
from patient 3; 4 – C. perfringens isolate no. 7149 from patient 2;
5 – C. perfringens isolate no. 7013 from patient 1.
C. perfringens isolates genotyping with the use of 
pulsed field gel electrophoresis (PFGE) indicated that 
the isolates originating from the three studied patients 
represent three genetically different restriction patterns 
and are related to each other in 66.7% (isolates no. 7143 
and 7149) and in 46.4% (isolates no. 7143, 7149 and 
7013). The isolates studied represented three different 
Using the Kirby-Bauer method and E-test, drug-
resistance patterns of the studied isolates were deter-
mined (Table II). In the EUCAST version 5.0 for 2015 
the criteria for determining susceptibility testing of 
anaerobic bacteria by disc diffusion method not yet 
been determined. However, in the case of the first and 
second patient, the isolated strains no. 7013 and 7149 
had the same drug-resistance patterns, while the isolate 
no. 7143 from the third patient had different antibiotic 
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PFGE types, which corresponded to three different 
clones – clone A (isolate no. 7143), clone B (isolate 
no. 7149) and clone C (isolate no. 7013) (Fig. 2).
gens etiology, 15–20% of isolates had this toxin (Fisher 
et al., 2005). Probably the synergic interactions of both 
toxins is of great importance.
cpa 324 bp α-toxin cpa cpa cpa
cpb 195 bp β-toxin – – –
cpb2 548 bp β2-toxin – cpb2 cpb2
etx 376 bp ε-toxin – – –
iap 272 bp ι-toxin – – –
cpe 485 bp enterotoxin – – –
Table III
Occurrence of genes encoding virulence factors in C. perfringens isolates.








Nowadays, in the USA about 1000 cases of gas 
gangrene are recorded each year (Abella et al., 2003). 
In Poland there are no epidemiological data concern-
ing this issue.
The three clinical cases of gas gangrene associated 
with C. perfringens described in this paper, ending 
with the death of two patients, confirm the fact that 
gas gangrene is an extremely severe surgical infection 
associated with high mortality. In our study the mor-
tality rate was 66,7%. Presently, gas gangrene is very 
rare, however, similar cases were described in Polish 
literature in the past (Wojdat et al., 2005; Stasiak et al., 
2007; Brzychczy-Włoch et al., 2014). 
The most important virulence factor of C. perfrin­
gens is α-toxin encoded by the gene cpa which possesses 
activities of lecithinase and haemolysine. α-toxin causes 
damage and lysis of cell membrane which has a lethal 
effect to different tissues. Moreover, this toxin has 
dermonecrotic properties and inhibits functions of 
neutrophils (Stevens and Bryant, 2002). Gibert et al. 
(1997) described the new toxin with cytotoxic ability 
called the β2-toxin (CPB2) encoded by a gene cpb2. In 
a study on patients with food poisoning of C. perfrin­
Fig. 2. Analysis of genetic profiles of C. perfringens isolates, subjected to DNA digestion by restriction enzyme SmaI,
carried out with the use of pulsed field gel electrophoresis (PFGE) method and GelCompare II software.
Legend: 7143 – C. perfringens isolate from patient 3; 7149 – C. perfringens isolate from patient 2; 7013 – C. perfringens isolate
from patient 1; REF – C. perfringens reference strain ATCC 12915.
With the use of multiplex PCR we detected the 
presence of cpa gene encoding α-toxin in all C. perfrin­
gens isolates originating from the three patients. Moreo-
ver, in two isolates from patient 2 and 3 the cpb2 gene 
encoding β2-toxin presence was confirmed. Described 
in the literature cases of gas gangrene were associated 
with the presence of α-toxin (Stevens and Bryant, 
2002; Stasiak et al., 2007). It is worth noting that in our 
study the presence of strains with additional β2-toxin, 
was associated with severe course of infection and the 
death of two patients.
Due to the fact that gas gangrene progresses rapidly 
and combined with irreversible soft tissue changes, the 
success of therapy very much depends on the time of 
the diagnosis on the basis of the clinical picture, bac-
teriological study results and the implementation of 
treatment. The close cooperation between a micro-
biological laboratory and a surgical staff is essential in 
proper management of gas gangrene (Sussmann et al., 
1998; Martirosian, 2007). 
Crystalline penicillin applied intravenously in high 
doses (e.g. 24 units per 24 h), most often combined with 
metronidazole, is the most often selected antibiotic in 
the treatment of gas gangrene. Supplementary effec- 
tive antibiotics are aminoglycosides, lincosamides e.g. 
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clindamycin, semisythetic penicillins e.g. amoxicillin, 
ticarcillin combined with bacterial β-lactamase inhi-
bitors e.g. clavulanic acid, fluoroquinolones and tetra-
cyclines coupled with aminoglycosides (Knap, 2004; 
Martirosian, 2007).
In three patients described, after isolation of C. per­
fringens from clinical materials, amoxicillin with clavu-
lanic acid in combination with clindamycin were used. 
However, despite adequate treatment implemented two 
of the patients died due to infection with C. perfringens 
and multiple organ failure.
In order to limit the epidemic outbreak a number 
of measures to identify the outbreak and to limit the 
spread of infection were taken. Unfortunately, in the 
cases described highlights a very long time (5  days) 
since the first strain of C. perfringens from the first 
patient were isolated, to forward this information to 
the Department of Orthopedics and the Hospital Infec-
tion Control Team. In the circumstances lacked a rapid 
response to the isolation of alert pathogen, which 
was associated with a high risk to other patients and 
the possibility of spread of the epidemic outbreak to 
other departments.
Microbiological studies were carried out in patients 
of the Department of Orthopedics, in the staff of the 
Department of Orthopedics, General Surgery, Anaes-
thesia and Intensive Care, and the Main Operating 
Theater and in the hospital environment. Despite the 
huge number of materials testing (total 563) in any 
case C. perfringens was not isolated. It indicates that 
the pathogen was not spread to other patients and did 
not get to the hospital environment. 
The treatment of gas gangrene should be complex. It 
consists in debridement, employment of empirical and 
targeted antibiotherapy as well as hyperbaric therapy. 
Hyperbaric oxygen therapy (HBOT) is effective in limi-
ting the number of toxins produced by C. perfringens 
that cause tissue necrosis in gas gangrene, and coupled 
with antibiotherapy, it reduces the time needed for 
treatment and significantly lowers mortality (Sussmann 
et al., 1998; Fielden et al., 2002; Martirosian, 2007). In 
the first patients described efforts were made to imple-
ment the HBOT but unfortunately it was not applied. 
Implementation of HBOT certainly would shorten 
the time of his hospitalization, which was as high as 
102 days, after which the patient in good condition was 
discharged at home.
Antiseptics effective against C. perfringens including 
spores are: 0.1% Octenisept, 10% Betadine or 5% Hibi-
tane (Stasiak et al., 2007). In described cases Octeni - 
sept rinsing was employed for debridement and rinsing 
of the wound. 
As shown in the studies, phenotypic characteris-
tics, including the determination of biochemical pro-
files and patterns of antibiotic resistance is inadequate 
in differentiating strains of C. perfringens. Molecular 
typing is of paramount importance in epidemiologi-
cal investigation testing, which tries to detect causes, 
sources and mechanisms of microorganisms spreading 
among patients, e.g. in a single hospital units (Fleischer 
and Salik, 2006; Brzychczy-Włoch et al., 2014). Detailed 
molecular studies using the PFGE method showed that 
C. perfringens strains isolated from the three patients 
represented three different genetic clones. This demon-
strates the different origins of these infections, which 
was the most likely source of endogenous flora in these 
patients. Similar results were also described earlier by 
our team, where there was an infection of C. perfringens 
of various origins in two patients simultaneously hospi-
talized in a single department (Brzychczy-Włoch et al., 
2014). Similar results were also described by Stasiak 
et al. (2007), who presented two patients with severe gas 
gangrene syndromes of a completely different origin.
Conclusions
As a result of the epidemiological and molecular 
study, it is possible to conclude that the three studied 
patients simultaneously hospitalized in a single Depart-
ment of Orthopedics and Traumatology with diag - 
nosed gas gangrene developed three different endo-
genous infection. 
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